Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(337)
•••
Comment by jayjay2020on Jul 15, 2019 2:29pm
102 Views
Post# 29921603

RE:RE:90 day review

RE:RE:90 day review
ediabid wrote: The use of the word review in the article could be the writer's.  In the youtube video, Irwin says "As I lay out the 90 day plan and the 120 day plan............".  I'm not sure whether Irwin's intention to lay out the plan to investors was ever specifically stated by him.  Check out the video around 4:44 to hear what he said. 

glta

GiddeeeUp wrote: People keep belaboring this 90 day thing misnaming it a ‘Plan’, it is just a review which may or may not be published. 

Irwin refs 90 day ‘review’ in article

Shorters and FUD-sters will post cr_p like this, don’t make these billboard part of your DD. 

G


Well said...  And why publicly reveal your plans anyway? Why give your competitors more information then they need?  Execute ... bring up revenue to a $1B + ... raise EBITDA .. that is all that matters at this stage..  

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities